nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Everolimus—kidney cancer	0.0883	0.208	CbGbCtD
Bexarotene—CYP3A4—Temsirolimus—kidney cancer	0.0596	0.141	CbGbCtD
Bexarotene—CYP2C9—Capecitabine—kidney cancer	0.0562	0.132	CbGbCtD
Bexarotene—CYP2C9—Paclitaxel—kidney cancer	0.0352	0.0829	CbGbCtD
Bexarotene—CYP3A4—Pazopanib—kidney cancer	0.0313	0.0738	CbGbCtD
Bexarotene—CYP2C9—Sorafenib—kidney cancer	0.0312	0.0737	CbGbCtD
Bexarotene—CYP3A4—Erlotinib—kidney cancer	0.0223	0.0527	CbGbCtD
Bexarotene—CYP3A4—Paclitaxel—kidney cancer	0.0205	0.0482	CbGbCtD
Bexarotene—CYP3A4—Sorafenib—kidney cancer	0.0182	0.0428	CbGbCtD
Bexarotene—CYP3A4—Vinblastine—kidney cancer	0.0179	0.0423	CbGbCtD
Bexarotene—CYP3A4—Vincristine—kidney cancer	0.0176	0.0416	CbGbCtD
Bexarotene—CYP3A4—Sunitinib—kidney cancer	0.0147	0.0347	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—kidney cancer	0.011	0.026	CbGbCtD
Bexarotene—RXRA—renal system—kidney cancer	0.000252	0.208	CbGeAlD
Bexarotene—CYP2C9—urine—kidney cancer	0.00025	0.206	CbGeAlD
Bexarotene—RXRA—kidney—kidney cancer	0.000244	0.201	CbGeAlD
Bexarotene—RXRA—Biological oxidations—GSTP1—kidney cancer	0.000223	0.00181	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TET2—kidney cancer	0.000221	0.00179	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HARS—kidney cancer	0.00022	0.00178	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—HIF1A—kidney cancer	0.000216	0.00175	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—TCEB2—kidney cancer	0.000215	0.00174	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—TCEB1—kidney cancer	0.000215	0.00174	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000212	0.00172	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—kidney cancer	0.000208	0.00168	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GSTM1—kidney cancer	0.000205	0.00166	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	0.000204	0.00165	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TCEB2—kidney cancer	0.000202	0.00164	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TCEB1—kidney cancer	0.000202	0.00164	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000201	0.00163	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.0002	0.00162	CbGpPWpGaD
Bexarotene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000199	0.00162	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000198	0.00161	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000195	0.00158	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—CYP1A1—kidney cancer	0.000194	0.00157	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000194	0.00157	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HNF1B—kidney cancer	0.000192	0.00155	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000191	0.00155	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000191	0.00155	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000191	0.00155	CbGpPWpGaD
Bexarotene—CYP3A4—urine—kidney cancer	0.000191	0.157	CbGeAlD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.00019	0.00154	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000189	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.000187	0.00152	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EIF5B—kidney cancer	0.000187	0.00151	CbGpPWpGaD
Bexarotene—RXRB—cardiac atrium—kidney cancer	0.000186	0.153	CbGeAlD
Bexarotene—RXRG—Gene Expression—RPL14—kidney cancer	0.000175	0.00142	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ACY1—kidney cancer	0.000171	0.00138	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000168	0.00136	CbGpPWpGaD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000166	0.00135	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RPL14—kidney cancer	0.000164	0.00133	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000146	0.00118	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PDHB—kidney cancer	0.000145	0.00118	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—POMC—kidney cancer	0.000145	0.00117	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—EIF4EBP1—kidney cancer	0.000143	0.00116	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HSPB1—kidney cancer	0.000143	0.00116	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.00014	0.00113	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00014	0.00113	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CTNNA1—kidney cancer	0.000137	0.00111	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000137	0.00111	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CCBL1—kidney cancer	0.000136	0.00111	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000136	0.00111	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000135	0.00109	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—EIF4EBP1—kidney cancer	0.000134	0.00109	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HSPB1—kidney cancer	0.000134	0.00109	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PSMD7—kidney cancer	0.000133	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PAX6—kidney cancer	0.000131	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CTNNB1—kidney cancer	0.000129	0.00105	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000125	0.00102	CbGpPWpGaD
Bexarotene—Fatigue—Gemcitabine—kidney cancer	0.000125	0.000277	CcSEcCtD
Bexarotene—Gastrointestinal pain—Vincristine—kidney cancer	0.000125	0.000277	CcSEcCtD
Bexarotene—RXRB—Gene Expression—PSMD7—kidney cancer	0.000125	0.00101	CbGpPWpGaD
Bexarotene—Dizziness—Sorafenib—kidney cancer	0.000124	0.000275	CcSEcCtD
Bexarotene—Constipation—Gemcitabine—kidney cancer	0.000124	0.000275	CcSEcCtD
Bexarotene—Pain—Gemcitabine—kidney cancer	0.000124	0.000275	CcSEcCtD
Bexarotene—Nausea—Erlotinib—kidney cancer	0.000124	0.000275	CcSEcCtD
Bexarotene—Alopecia—Capecitabine—kidney cancer	0.000124	0.000274	CcSEcCtD
Bexarotene—Dry mouth—Paclitaxel—kidney cancer	0.000124	0.000274	CcSEcCtD
Bexarotene—Mood swings—Doxorubicin—kidney cancer	0.000124	0.000274	CcSEcCtD
Bexarotene—Diarrhoea—Sunitinib—kidney cancer	0.000124	0.000274	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000123	0.001	CbGpPWpGaD
Bexarotene—Ataxia—Doxorubicin—kidney cancer	0.000123	0.000272	CcSEcCtD
Bexarotene—Asthenia—Dactinomycin—kidney cancer	0.000123	0.000272	CcSEcCtD
Bexarotene—Confusional state—Paclitaxel—kidney cancer	0.000122	0.000271	CcSEcCtD
Bexarotene—Blood creatinine increased—Doxorubicin—kidney cancer	0.000122	0.000271	CcSEcCtD
Bexarotene—Malnutrition—Capecitabine—kidney cancer	0.000122	0.00027	CcSEcCtD
Bexarotene—Erythema—Capecitabine—kidney cancer	0.000122	0.00027	CcSEcCtD
Bexarotene—Dehydration—Doxorubicin—kidney cancer	0.000121	0.000269	CcSEcCtD
Bexarotene—Oedema—Paclitaxel—kidney cancer	0.000121	0.000269	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—JUNB—kidney cancer	0.000121	0.000981	CbGpPWpGaD
Bexarotene—Body temperature increased—Vincristine—kidney cancer	0.000121	0.000268	CcSEcCtD
Bexarotene—Abdominal pain—Vincristine—kidney cancer	0.000121	0.000268	CcSEcCtD
Bexarotene—Liver function test abnormal—Doxorubicin—kidney cancer	0.000121	0.000267	CcSEcCtD
Bexarotene—Infection—Paclitaxel—kidney cancer	0.000121	0.000267	CcSEcCtD
Bexarotene—RXRA—Gene Expression—EEF2—kidney cancer	0.00012	0.000975	CbGpPWpGaD
Bexarotene—Flatulence—Capecitabine—kidney cancer	0.00012	0.000266	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.00012	0.000972	CbGpPWpGaD
Bexarotene—Dry skin—Doxorubicin—kidney cancer	0.00012	0.000265	CcSEcCtD
Bexarotene—Dysgeusia—Capecitabine—kidney cancer	0.000119	0.000265	CcSEcCtD
Bexarotene—Dizziness—Sunitinib—kidney cancer	0.000119	0.000265	CcSEcCtD
Bexarotene—Feeling abnormal—Gemcitabine—kidney cancer	0.000119	0.000265	CcSEcCtD
Bexarotene—Shock—Paclitaxel—kidney cancer	0.000119	0.000265	CcSEcCtD
Bexarotene—Vomiting—Sorafenib—kidney cancer	0.000119	0.000264	CcSEcCtD
Bexarotene—RXRG—Gene Expression—JUNB—kidney cancer	0.000119	0.000964	CbGpPWpGaD
Bexarotene—Nervous system disorder—Paclitaxel—kidney cancer	0.000119	0.000264	CcSEcCtD
Bexarotene—Hypokalaemia—Doxorubicin—kidney cancer	0.000119	0.000263	CcSEcCtD
Bexarotene—Thrombocytopenia—Paclitaxel—kidney cancer	0.000119	0.000263	CcSEcCtD
Bexarotene—Tachycardia—Paclitaxel—kidney cancer	0.000118	0.000262	CcSEcCtD
Bexarotene—Rash—Sorafenib—kidney cancer	0.000118	0.000262	CcSEcCtD
Bexarotene—RXRA—Metabolism—GLIPR1—kidney cancer	0.000118	0.000959	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPAT—kidney cancer	0.000118	0.000959	CbGpPWpGaD
Bexarotene—Dermatitis—Sorafenib—kidney cancer	0.000118	0.000262	CcSEcCtD
Bexarotene—Back pain—Capecitabine—kidney cancer	0.000118	0.000261	CcSEcCtD
Bexarotene—Skin disorder—Paclitaxel—kidney cancer	0.000118	0.000261	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000118	0.000261	CcSEcCtD
Bexarotene—Headache—Sorafenib—kidney cancer	0.000118	0.000261	CcSEcCtD
Bexarotene—Muscle spasms—Capecitabine—kidney cancer	0.000117	0.00026	CcSEcCtD
Bexarotene—Hyperhidrosis—Paclitaxel—kidney cancer	0.000117	0.00026	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—kidney cancer	0.000117	0.000259	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000117	0.000947	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000116	0.000938	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000116	0.000937	CbGpPWpGaD
Bexarotene—Anorexia—Paclitaxel—kidney cancer	0.000116	0.000256	CcSEcCtD
Bexarotene—RXRA—Gene Expression—TET2—kidney cancer	0.000115	0.000934	CbGpPWpGaD
Bexarotene—Muscular weakness—Doxorubicin—kidney cancer	0.000115	0.000255	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000115	0.000255	CcSEcCtD
Bexarotene—Vomiting—Sunitinib—kidney cancer	0.000115	0.000254	CcSEcCtD
Bexarotene—Body temperature increased—Gemcitabine—kidney cancer	0.000115	0.000254	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—PAK1—kidney cancer	0.000114	0.000924	CbGpPWpGaD
Bexarotene—Rash—Sunitinib—kidney cancer	0.000114	0.000252	CcSEcCtD
Bexarotene—Dermatitis—Sunitinib—kidney cancer	0.000114	0.000252	CcSEcCtD
Bexarotene—Abdominal distension—Doxorubicin—kidney cancer	0.000114	0.000252	CcSEcCtD
Bexarotene—Ill-defined disorder—Capecitabine—kidney cancer	0.000113	0.000251	CcSEcCtD
Bexarotene—Headache—Sunitinib—kidney cancer	0.000113	0.000251	CcSEcCtD
Bexarotene—Influenza—Doxorubicin—kidney cancer	0.000113	0.00025	CcSEcCtD
Bexarotene—Dysphagia—Doxorubicin—kidney cancer	0.000113	0.00025	CcSEcCtD
Bexarotene—Anaemia—Capecitabine—kidney cancer	0.000113	0.00025	CcSEcCtD
Bexarotene—Hypersensitivity—Vincristine—kidney cancer	0.000113	0.000249	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000112	0.000911	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—JUNB—kidney cancer	0.000112	0.000907	CbGpPWpGaD
Bexarotene—Eosinophilia—Doxorubicin—kidney cancer	0.000112	0.000248	CcSEcCtD
Bexarotene—Nausea—Sorafenib—kidney cancer	0.000111	0.000247	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000111	0.000899	CbGpPWpGaD
Bexarotene—Pancreatitis—Doxorubicin—kidney cancer	0.000111	0.000245	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000111	0.000245	CcSEcCtD
Bexarotene—Malaise—Capecitabine—kidney cancer	0.00011	0.000244	CcSEcCtD
Bexarotene—RXRA—Metabolism—APRT—kidney cancer	0.00011	0.000891	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FH—kidney cancer	0.00011	0.000891	CbGpPWpGaD
Bexarotene—Angina pectoris—Doxorubicin—kidney cancer	0.00011	0.000244	CcSEcCtD
Bexarotene—Insomnia—Paclitaxel—kidney cancer	0.00011	0.000243	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.00011	0.000889	CbGpPWpGaD
Bexarotene—Vertigo—Capecitabine—kidney cancer	0.00011	0.000243	CcSEcCtD
Bexarotene—Asthenia—Vincristine—kidney cancer	0.00011	0.000243	CcSEcCtD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000109	0.000887	CbGpPWpGaD
Bexarotene—Syncope—Capecitabine—kidney cancer	0.000109	0.000242	CcSEcCtD
Bexarotene—Leukopenia—Capecitabine—kidney cancer	0.000109	0.000242	CcSEcCtD
Bexarotene—Paraesthesia—Paclitaxel—kidney cancer	0.000109	0.000241	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—kidney cancer	0.000109	0.000241	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000109	0.000879	CbGpPWpGaD
Bexarotene—Bronchitis—Doxorubicin—kidney cancer	0.000109	0.000241	CcSEcCtD
Bexarotene—Dyspnoea—Paclitaxel—kidney cancer	0.000108	0.00024	CcSEcCtD
Bexarotene—Somnolence—Paclitaxel—kidney cancer	0.000108	0.000239	CcSEcCtD
Bexarotene—Palpitations—Capecitabine—kidney cancer	0.000108	0.000239	CcSEcCtD
Bexarotene—Rash—Dactinomycin—kidney cancer	0.000108	0.000239	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000108	0.000871	CbGpPWpGaD
Bexarotene—Nausea—Sunitinib—kidney cancer	0.000107	0.000238	CcSEcCtD
Bexarotene—Loss of consciousness—Capecitabine—kidney cancer	0.000107	0.000238	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—kidney cancer	0.000107	0.000238	CcSEcCtD
Bexarotene—Dyspepsia—Paclitaxel—kidney cancer	0.000107	0.000237	CcSEcCtD
Bexarotene—Cough—Capecitabine—kidney cancer	0.000106	0.000236	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000106	0.00086	CbGpPWpGaD
Bexarotene—Dysuria—Doxorubicin—kidney cancer	0.000106	0.000234	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—kidney cancer	0.000106	0.000234	CcSEcCtD
Bexarotene—RXRA—Gene Expression—TCEB2—kidney cancer	0.000105	0.000855	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—TCEB1—kidney cancer	0.000105	0.000855	CbGpPWpGaD
Bexarotene—Decreased appetite—Paclitaxel—kidney cancer	0.000105	0.000234	CcSEcCtD
Bexarotene—Hypertension—Capecitabine—kidney cancer	0.000105	0.000233	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000105	0.000232	CcSEcCtD
Bexarotene—Fatigue—Paclitaxel—kidney cancer	0.000105	0.000232	CcSEcCtD
Bexarotene—Diarrhoea—Vincristine—kidney cancer	0.000105	0.000232	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—kidney cancer	0.000104	0.000231	CcSEcCtD
Bexarotene—Asthenia—Gemcitabine—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Arthralgia—Capecitabine—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Myalgia—Capecitabine—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Chest pain—Capecitabine—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Pain—Paclitaxel—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Constipation—Paclitaxel—kidney cancer	0.000104	0.00023	CcSEcCtD
Bexarotene—Anxiety—Capecitabine—kidney cancer	0.000103	0.000229	CcSEcCtD
Bexarotene—RXRA—Metabolism—GPC3—kidney cancer	0.000103	0.000838	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000103	0.000229	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000103	0.000228	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—kidney cancer	0.000103	0.000228	CcSEcCtD
Bexarotene—Discomfort—Capecitabine—kidney cancer	0.000103	0.000227	CcSEcCtD
Bexarotene—Pruritus—Gemcitabine—kidney cancer	0.000103	0.000227	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—kidney cancer	0.000102	0.000226	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—kidney cancer	0.000102	0.000226	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000102	0.000824	CbGpPWpGaD
Bexarotene—Dry mouth—Capecitabine—kidney cancer	0.000102	0.000225	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—kidney cancer	0.000102	0.000225	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—kidney cancer	0.000101	0.000224	CcSEcCtD
Bexarotene—Dizziness—Vincristine—kidney cancer	0.000101	0.000224	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000101	0.000818	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CA2—kidney cancer	0.000101	0.000815	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000101	0.000814	CbGpPWpGaD
Bexarotene—Confusional state—Capecitabine—kidney cancer	0.0001	0.000222	CcSEcCtD
Bexarotene—Feeling abnormal—Paclitaxel—kidney cancer	0.0001	0.000222	CcSEcCtD
Bexarotene—Oedema—Capecitabine—kidney cancer	9.96e-05	0.000221	CcSEcCtD
Bexarotene—Gastrointestinal pain—Paclitaxel—kidney cancer	9.92e-05	0.00022	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.92e-05	0.000804	CbGpPWpGaD
Bexarotene—Diarrhoea—Gemcitabine—kidney cancer	9.91e-05	0.00022	CcSEcCtD
Bexarotene—Infection—Capecitabine—kidney cancer	9.89e-05	0.000219	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—kidney cancer	9.86e-05	0.000219	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—CDKN2B—kidney cancer	9.86e-05	0.000799	CbGpPWpGaD
Bexarotene—Jaundice—Doxorubicin—kidney cancer	9.81e-05	0.000217	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—kidney cancer	9.81e-05	0.000217	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALAD—kidney cancer	9.8e-05	0.000794	CbGpPWpGaD
Bexarotene—Shock—Capecitabine—kidney cancer	9.79e-05	0.000217	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—kidney cancer	9.78e-05	0.000217	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—kidney cancer	9.78e-05	0.000217	CcSEcCtD
Bexarotene—Nervous system disorder—Capecitabine—kidney cancer	9.76e-05	0.000216	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.75e-05	0.00079	CbGpPWpGaD
Bexarotene—Thrombocytopenia—Capecitabine—kidney cancer	9.75e-05	0.000216	CcSEcCtD
Bexarotene—Tachycardia—Capecitabine—kidney cancer	9.72e-05	0.000215	CcSEcCtD
Bexarotene—Vomiting—Vincristine—kidney cancer	9.71e-05	0.000215	CcSEcCtD
Bexarotene—RXRG—Gene Expression—CDKN2B—kidney cancer	9.69e-05	0.000785	CbGpPWpGaD
Bexarotene—Skin disorder—Capecitabine—kidney cancer	9.67e-05	0.000214	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—kidney cancer	9.65e-05	0.000214	CcSEcCtD
Bexarotene—Rash—Vincristine—kidney cancer	9.63e-05	0.000213	CcSEcCtD
Bexarotene—Hyperhidrosis—Capecitabine—kidney cancer	9.62e-05	0.000213	CcSEcCtD
Bexarotene—Dermatitis—Vincristine—kidney cancer	9.62e-05	0.000213	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—kidney cancer	9.59e-05	0.000213	CcSEcCtD
Bexarotene—Abdominal pain—Paclitaxel—kidney cancer	9.59e-05	0.000213	CcSEcCtD
Bexarotene—Body temperature increased—Paclitaxel—kidney cancer	9.59e-05	0.000213	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.59e-05	0.000777	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ST3GAL2—kidney cancer	9.57e-05	0.000775	CbGpPWpGaD
Bexarotene—Headache—Vincristine—kidney cancer	9.57e-05	0.000212	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.57e-05	0.000775	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.5e-05	0.000769	CbGpPWpGaD
Bexarotene—Epistaxis—Doxorubicin—kidney cancer	9.49e-05	0.00021	CcSEcCtD
Bexarotene—Anorexia—Capecitabine—kidney cancer	9.49e-05	0.00021	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—kidney cancer	9.44e-05	0.000209	CcSEcCtD
Bexarotene—RXRA—Metabolism—ALDH1A1—kidney cancer	9.35e-05	0.000758	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	9.26e-05	0.00075	CbGpPWpGaD
Bexarotene—Vomiting—Gemcitabine—kidney cancer	9.21e-05	0.000204	CcSEcCtD
Bexarotene—Rash—Gemcitabine—kidney cancer	9.14e-05	0.000202	CcSEcCtD
Bexarotene—Dermatitis—Gemcitabine—kidney cancer	9.13e-05	0.000202	CcSEcCtD
Bexarotene—RXRB—Gene Expression—CDKN2B—kidney cancer	9.11e-05	0.000738	CbGpPWpGaD
Bexarotene—Haemoglobin—Doxorubicin—kidney cancer	9.08e-05	0.000201	CcSEcCtD
Bexarotene—Headache—Gemcitabine—kidney cancer	9.08e-05	0.000201	CcSEcCtD
Bexarotene—Nausea—Vincristine—kidney cancer	9.07e-05	0.000201	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.07e-05	0.000201	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—kidney cancer	9.06e-05	0.000201	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—kidney cancer	9.03e-05	0.0002	CcSEcCtD
Bexarotene—Insomnia—Capecitabine—kidney cancer	9e-05	0.0002	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.99e-05	0.000729	CbGpPWpGaD
Bexarotene—Hypoaesthesia—Doxorubicin—kidney cancer	8.99e-05	0.000199	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC5A3—kidney cancer	8.97e-05	0.000727	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PGK1—kidney cancer	8.97e-05	0.000727	CbGpPWpGaD
Bexarotene—Pharyngitis—Doxorubicin—kidney cancer	8.97e-05	0.000199	CcSEcCtD
Bexarotene—Paraesthesia—Capecitabine—kidney cancer	8.94e-05	0.000198	CcSEcCtD
Bexarotene—Hypersensitivity—Paclitaxel—kidney cancer	8.94e-05	0.000198	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—kidney cancer	8.92e-05	0.000198	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—kidney cancer	8.9e-05	0.000197	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—kidney cancer	8.88e-05	0.000197	CcSEcCtD
Bexarotene—Dyspnoea—Capecitabine—kidney cancer	8.88e-05	0.000197	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—kidney cancer	8.85e-05	0.000196	CcSEcCtD
Bexarotene—RXRA—Metabolism—LDHB—kidney cancer	8.79e-05	0.000713	CbGpPWpGaD
Bexarotene—Dyspepsia—Capecitabine—kidney cancer	8.76e-05	0.000194	CcSEcCtD
Bexarotene—Asthenia—Paclitaxel—kidney cancer	8.7e-05	0.000193	CcSEcCtD
Bexarotene—Decreased appetite—Capecitabine—kidney cancer	8.65e-05	0.000192	CcSEcCtD
Bexarotene—Nausea—Gemcitabine—kidney cancer	8.61e-05	0.000191	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Capecitabine—kidney cancer	8.6e-05	0.00019	CcSEcCtD
Bexarotene—Fatigue—Capecitabine—kidney cancer	8.58e-05	0.00019	CcSEcCtD
Bexarotene—Pruritus—Paclitaxel—kidney cancer	8.58e-05	0.00019	CcSEcCtD
Bexarotene—RXRA—Gene Expression—RPL14—kidney cancer	8.57e-05	0.000694	CbGpPWpGaD
Bexarotene—Constipation—Capecitabine—kidney cancer	8.51e-05	0.000189	CcSEcCtD
Bexarotene—Pain—Capecitabine—kidney cancer	8.51e-05	0.000189	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—kidney cancer	8.44e-05	0.000187	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—kidney cancer	8.42e-05	0.000187	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—kidney cancer	8.38e-05	0.000186	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.36e-05	0.000677	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTP1—kidney cancer	8.32e-05	0.000674	CbGpPWpGaD
Bexarotene—Diarrhoea—Paclitaxel—kidney cancer	8.3e-05	0.000184	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.27e-05	0.00067	CbGpPWpGaD
Bexarotene—Feeling abnormal—Capecitabine—kidney cancer	8.2e-05	0.000182	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	8.2e-05	0.000665	CbGpPWpGaD
Bexarotene—Angiopathy—Doxorubicin—kidney cancer	8.2e-05	0.000182	CcSEcCtD
Bexarotene—Gastrointestinal pain—Capecitabine—kidney cancer	8.14e-05	0.00018	CcSEcCtD
Bexarotene—Chills—Doxorubicin—kidney cancer	8.1e-05	0.00018	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—kidney cancer	8.07e-05	0.000179	CcSEcCtD
Bexarotene—Dizziness—Paclitaxel—kidney cancer	8.02e-05	0.000178	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—kidney cancer	7.98e-05	0.000177	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTT1—kidney cancer	7.91e-05	0.000641	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.91e-05	0.000641	CbGpPWpGaD
Bexarotene—Abdominal pain—Capecitabine—kidney cancer	7.87e-05	0.000174	CcSEcCtD
Bexarotene—Body temperature increased—Capecitabine—kidney cancer	7.87e-05	0.000174	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—kidney cancer	7.86e-05	0.000174	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—kidney cancer	7.86e-05	0.000174	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—kidney cancer	7.8e-05	0.000632	CbGpPWpGaD
Bexarotene—Flatulence—Doxorubicin—kidney cancer	7.75e-05	0.000172	CcSEcCtD
Bexarotene—Tension—Doxorubicin—kidney cancer	7.72e-05	0.000171	CcSEcCtD
Bexarotene—Vomiting—Paclitaxel—kidney cancer	7.71e-05	0.000171	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—kidney cancer	7.7e-05	0.000171	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.7e-05	0.000624	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.69e-05	0.000623	CbGpPWpGaD
Bexarotene—Rash—Paclitaxel—kidney cancer	7.65e-05	0.00017	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—kidney cancer	7.64e-05	0.000619	CbGpPWpGaD
Bexarotene—Dermatitis—Paclitaxel—kidney cancer	7.64e-05	0.000169	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—kidney cancer	7.64e-05	0.000169	CcSEcCtD
Bexarotene—RXRA—Metabolism—CA9—kidney cancer	7.62e-05	0.000618	CbGpPWpGaD
Bexarotene—Back pain—Doxorubicin—kidney cancer	7.61e-05	0.000169	CcSEcCtD
Bexarotene—Headache—Paclitaxel—kidney cancer	7.6e-05	0.000168	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—kidney cancer	7.56e-05	0.000168	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	7.54e-05	0.000611	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.52e-05	0.00061	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.45e-05	0.000604	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.41e-05	0.000601	CbGpPWpGaD
Bexarotene—Hypersensitivity—Capecitabine—kidney cancer	7.33e-05	0.000163	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—kidney cancer	7.33e-05	0.000594	CbGpPWpGaD
Bexarotene—Ill-defined disorder—Doxorubicin—kidney cancer	7.3e-05	0.000162	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—kidney cancer	7.27e-05	0.000161	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	7.24e-05	0.000587	CbGpPWpGaD
Bexarotene—Agitation—Doxorubicin—kidney cancer	7.23e-05	0.00016	CcSEcCtD
Bexarotene—Nausea—Paclitaxel—kidney cancer	7.21e-05	0.00016	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	7.15e-05	0.000579	CbGpPWpGaD
Bexarotene—Asthenia—Capecitabine—kidney cancer	7.14e-05	0.000158	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.11e-05	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KDR—kidney cancer	7.09e-05	0.000575	CbGpPWpGaD
Bexarotene—Malaise—Doxorubicin—kidney cancer	7.09e-05	0.000157	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—kidney cancer	7.06e-05	0.000157	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—kidney cancer	7.05e-05	0.000156	CcSEcCtD
Bexarotene—Pruritus—Capecitabine—kidney cancer	7.04e-05	0.000156	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—kidney cancer	7.04e-05	0.000156	CcSEcCtD
Bexarotene—RXRA—Gene Expression—EIF4EBP1—kidney cancer	6.99e-05	0.000566	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPB1—kidney cancer	6.99e-05	0.000566	CbGpPWpGaD
Bexarotene—Palpitations—Doxorubicin—kidney cancer	6.95e-05	0.000154	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—MET—kidney cancer	6.94e-05	0.000563	CbGpPWpGaD
Bexarotene—Loss of consciousness—Doxorubicin—kidney cancer	6.91e-05	0.000153	CcSEcCtD
Bexarotene—Cough—Doxorubicin—kidney cancer	6.86e-05	0.000152	CcSEcCtD
Bexarotene—Diarrhoea—Capecitabine—kidney cancer	6.81e-05	0.000151	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—kidney cancer	6.79e-05	0.00015	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.71e-05	0.000543	CbGpPWpGaD
Bexarotene—Arthralgia—Doxorubicin—kidney cancer	6.69e-05	0.000148	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—kidney cancer	6.69e-05	0.000148	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—kidney cancer	6.69e-05	0.000148	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—kidney cancer	6.67e-05	0.000148	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.65e-05	0.000147	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—kidney cancer	6.61e-05	0.000147	CcSEcCtD
Bexarotene—Dizziness—Capecitabine—kidney cancer	6.58e-05	0.000146	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—kidney cancer	6.55e-05	0.000145	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.53e-05	0.000529	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PSMD7—kidney cancer	6.5e-05	0.000526	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CRABP1—kidney cancer	6.48e-05	0.000525	CbGpPWpGaD
Bexarotene—Confusional state—Doxorubicin—kidney cancer	6.47e-05	0.000143	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—kidney cancer	6.42e-05	0.000142	CcSEcCtD
Bexarotene—Infection—Doxorubicin—kidney cancer	6.38e-05	0.000141	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—ACY1—kidney cancer	6.37e-05	0.000516	CbGpPWpGaD
Bexarotene—Vomiting—Capecitabine—kidney cancer	6.33e-05	0.00014	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.32e-05	0.000512	CbGpPWpGaD
Bexarotene—Shock—Doxorubicin—kidney cancer	6.31e-05	0.00014	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—kidney cancer	6.29e-05	0.000139	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—kidney cancer	6.28e-05	0.000139	CcSEcCtD
Bexarotene—Rash—Capecitabine—kidney cancer	6.28e-05	0.000139	CcSEcCtD
Bexarotene—Dermatitis—Capecitabine—kidney cancer	6.27e-05	0.000139	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—kidney cancer	6.26e-05	0.000139	CcSEcCtD
Bexarotene—Headache—Capecitabine—kidney cancer	6.24e-05	0.000138	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—kidney cancer	6.23e-05	0.000138	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—kidney cancer	6.2e-05	0.000137	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—kidney cancer	6.12e-05	0.000136	CcSEcCtD
Bexarotene—RXRA—Metabolism—ITPR2—kidney cancer	6.03e-05	0.000488	CbGpPWpGaD
Bexarotene—Nausea—Capecitabine—kidney cancer	5.91e-05	0.000131	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.85e-05	0.00013	CcSEcCtD
Bexarotene—RXRA—Gene Expression—JUNB—kidney cancer	5.83e-05	0.000472	CbGpPWpGaD
Bexarotene—Insomnia—Doxorubicin—kidney cancer	5.8e-05	0.000129	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—kidney cancer	5.76e-05	0.000128	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—kidney cancer	5.72e-05	0.000127	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—kidney cancer	5.71e-05	0.000126	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—kidney cancer	5.65e-05	0.000125	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—kidney cancer	5.58e-05	0.000124	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.56e-05	0.00045	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.54e-05	0.000123	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—kidney cancer	5.53e-05	0.000123	CcSEcCtD
Bexarotene—RXRA—Metabolism—ACHE—kidney cancer	5.5e-05	0.000445	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTT1—kidney cancer	5.5e-05	0.000445	CbGpPWpGaD
Bexarotene—Pain—Doxorubicin—kidney cancer	5.49e-05	0.000122	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—kidney cancer	5.49e-05	0.000122	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.48e-05	0.000444	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.43e-05	0.00044	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PDHB—kidney cancer	5.42e-05	0.000439	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.41e-05	0.000438	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—kidney cancer	5.4e-05	0.000438	CbGpPWpGaD
Bexarotene—Feeling abnormal—Doxorubicin—kidney cancer	5.29e-05	0.000117	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—kidney cancer	5.25e-05	0.000116	CcSEcCtD
Bexarotene—RXRA—Metabolism—SCARB1—kidney cancer	5.2e-05	0.000422	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS1—kidney cancer	5.15e-05	0.000417	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RAF1—kidney cancer	5.13e-05	0.000416	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RELA—kidney cancer	5.11e-05	0.000414	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CCBL1—kidney cancer	5.09e-05	0.000413	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ERBB2—kidney cancer	5.07e-05	0.000411	CbGpPWpGaD
Bexarotene—Body temperature increased—Doxorubicin—kidney cancer	5.07e-05	0.000112	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—kidney cancer	5.07e-05	0.000112	CcSEcCtD
Bexarotene—RXRA—Metabolism—PSMD7—kidney cancer	5.05e-05	0.000409	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.04e-05	0.000408	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.97e-05	0.000403	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BCHE—kidney cancer	4.79e-05	0.000388	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.78e-05	0.000387	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CDKN2B—kidney cancer	4.75e-05	0.000385	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC5A5—kidney cancer	4.73e-05	0.000383	CbGpPWpGaD
Bexarotene—Hypersensitivity—Doxorubicin—kidney cancer	4.73e-05	0.000105	CcSEcCtD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.71e-05	0.000382	CbGpPWpGaD
Bexarotene—CYP3A4—renal system—kidney cancer	4.66e-05	0.0384	CbGeAlD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.61e-05	0.000373	CbGpPWpGaD
Bexarotene—Asthenia—Doxorubicin—kidney cancer	4.6e-05	0.000102	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC2A1—kidney cancer	4.57e-05	0.00037	CbGpPWpGaD
Bexarotene—Pruritus—Doxorubicin—kidney cancer	4.54e-05	0.000101	CcSEcCtD
Bexarotene—CYP3A4—kidney—kidney cancer	4.51e-05	0.0371	CbGeAlD
Bexarotene—RXRA—Developmental Biology—CTNNB1—kidney cancer	4.44e-05	0.00036	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.43e-05	0.000359	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPAT—kidney cancer	4.42e-05	0.000358	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.42e-05	0.000358	CbGpPWpGaD
Bexarotene—Diarrhoea—Doxorubicin—kidney cancer	4.39e-05	9.73e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.36e-05	0.000353	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	4.36e-05	0.000353	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.32e-05	0.00035	CbGpPWpGaD
Bexarotene—Dizziness—Doxorubicin—kidney cancer	4.24e-05	9.4e-05	CcSEcCtD
Bexarotene—CYP3A4—Metabolism—ACY1—kidney cancer	4.2e-05	0.000341	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FH—kidney cancer	4.11e-05	0.000333	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APRT—kidney cancer	4.11e-05	0.000333	CbGpPWpGaD
Bexarotene—Vomiting—Doxorubicin—kidney cancer	4.08e-05	9.04e-05	CcSEcCtD
Bexarotene—Rash—Doxorubicin—kidney cancer	4.05e-05	8.97e-05	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—kidney cancer	4.04e-05	8.96e-05	CcSEcCtD
Bexarotene—Headache—Doxorubicin—kidney cancer	4.02e-05	8.91e-05	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.01e-05	0.000325	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—kidney cancer	3.91e-05	0.000317	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.86e-05	0.000313	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPC3—kidney cancer	3.86e-05	0.000313	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK3—kidney cancer	3.86e-05	0.000313	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—kidney cancer	3.82e-05	0.00031	CbGpPWpGaD
Bexarotene—Nausea—Doxorubicin—kidney cancer	3.81e-05	8.45e-05	CcSEcCtD
Bexarotene—RXRA—Metabolism—GSTP1—kidney cancer	3.81e-05	0.000309	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA2—kidney cancer	3.76e-05	0.000304	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—kidney cancer	3.75e-05	0.000304	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK3—kidney cancer	3.7e-05	0.0003	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALAD—kidney cancer	3.66e-05	0.000297	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK3—kidney cancer	3.63e-05	0.000294	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCB1—kidney cancer	3.61e-05	0.000292	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDHB—kidney cancer	3.57e-05	0.00029	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.57e-05	0.000289	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—kidney cancer	3.56e-05	0.000289	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—kidney cancer	3.53e-05	0.000286	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK1—kidney cancer	3.52e-05	0.000285	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—kidney cancer	3.5e-05	0.000284	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.49e-05	0.000283	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CCBL1—kidney cancer	3.36e-05	0.000272	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.35e-05	0.000271	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PGK1—kidney cancer	3.35e-05	0.000271	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—kidney cancer	3.32e-05	0.000269	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1A1—kidney cancer	3.32e-05	0.000269	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LDHB—kidney cancer	3.28e-05	0.000266	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.91e-05	0.000236	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPAT—kidney cancer	2.91e-05	0.000236	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA9—kidney cancer	2.85e-05	0.000231	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.78e-05	0.000225	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.73e-05	0.000221	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APRT—kidney cancer	2.71e-05	0.000219	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FH—kidney cancer	2.71e-05	0.000219	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPC3—kidney cancer	2.55e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA2—kidney cancer	2.48e-05	0.000201	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—kidney cancer	2.47e-05	0.0002	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CRABP1—kidney cancer	2.42e-05	0.000196	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALAD—kidney cancer	2.41e-05	0.000196	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.36e-05	0.000191	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.3e-05	0.000187	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ITPR2—kidney cancer	2.25e-05	0.000182	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGK1—kidney cancer	2.21e-05	0.000179	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.21e-05	0.000179	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDHB—kidney cancer	2.17e-05	0.000175	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.07e-05	0.000168	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—kidney cancer	2.05e-05	0.000166	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACHE—kidney cancer	2.05e-05	0.000166	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—kidney cancer	1.97e-05	0.00016	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SCARB1—kidney cancer	1.94e-05	0.000157	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS1—kidney cancer	1.92e-05	0.000156	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK3—kidney cancer	1.89e-05	0.000153	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMD7—kidney cancer	1.89e-05	0.000153	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA9—kidney cancer	1.88e-05	0.000152	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—kidney cancer	1.84e-05	0.000149	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BCHE—kidney cancer	1.79e-05	0.000145	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.77e-05	0.000143	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—kidney cancer	1.72e-05	0.000139	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.71e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.65e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CRABP1—kidney cancer	1.6e-05	0.000129	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ITPR2—kidney cancer	1.48e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.44e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000115	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACHE—kidney cancer	1.35e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—kidney cancer	1.35e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCB1—kidney cancer	1.35e-05	0.000109	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—kidney cancer	1.31e-05	0.000106	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SCARB1—kidney cancer	1.28e-05	0.000104	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS1—kidney cancer	1.27e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMD7—kidney cancer	1.24e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.24e-05	0.0001	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—kidney cancer	1.21e-05	9.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BCHE—kidney cancer	1.18e-05	9.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.16e-05	9.44e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.12e-05	9.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.02e-05	8.25e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—kidney cancer	9.38e-06	7.6e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—kidney cancer	9.24e-06	7.49e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCB1—kidney cancer	8.88e-06	7.19e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—kidney cancer	8.62e-06	6.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.17e-06	6.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—kidney cancer	7.37e-06	5.97e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—kidney cancer	6.43e-06	5.21e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—kidney cancer	6.09e-06	4.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—kidney cancer	4.86e-06	3.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.53e-06	3.67e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—kidney cancer	4.24e-06	3.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.99e-06	2.42e-05	CbGpPWpGaD
